Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs
✍ Scribed by Chen, Jun; Lu, Wen-Li; Gu, Wei; Lu, Shan-Shan; Chen, Zhi-Peng; Cai, Bao-Chang; Yang, Xi-Xiong
- Book ID
- 121761454
- Publisher
- Informa plc
- Year
- 2014
- Tongue
- English
- Weight
- 784 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1742-5247
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Liposomal drug-delivery systems have come of age in recent years, with several liposomal drugs currently in advanced clinical trials or already on the market. It is clear from numerous pre-clinical and clinical studies that drugs, such as antitumor drugs, packaged in liposomes exhibit reduced toxici
## Abstract We used the membrane‐impermeable nitroxyl radical 4‐trimethylammonium‐2,2,6,6‐tetramethylpiperidine‐1‐oxyliodide (CAT‐1) as a model drug encapsulated in liposomes in order to separately map the 2D distribution of both liposomal‐encapsulated CAT‐1 and free CAT‐1. Phantoms were prepared w
Since the discovery of liposomes or lipid vesicles derived from self-forming enclosed lipid bilayers upon hydration, liposome drug delivery systems have played a signi®cant role in formulation of potent drugs to improve therapeutics. Currently, most of these liposome formulations are designed to red
The development of successful formulations for poorly water soluble drugs remains a longstanding, critical, and challenging issue in cancer therapy. A b-cyclodextrin (CD) functionalized hyperbranched polyglycerol (HPG) has been prepared as a potential water insoluble drug carrier. The HPG-g-CD molec